BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34963561)

  • 21. Amsacrine downregulates BCL2L1 expression and triggers apoptosis in human chronic myeloid leukemia cells through the SIDT2/NOX4/ERK/HuR pathway.
    Lee YC; Chiou JT; Wang LJ; Chen YJ; Chang LS
    Toxicol Appl Pharmacol; 2023 Sep; 474():116625. PubMed ID: 37451322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hydroquinone destabilizes BIM mRNA through upregulation of p62 in chronic myeloid leukemia cells.
    Lee YC; Chiou JT; Wang LJ; Chang LS
    Biochem Pharmacol; 2022 May; 199():115017. PubMed ID: 35346662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arsenic trioxide-induced p38 MAPK and Akt mediated MCL1 downregulation causes apoptosis of BCR-ABL1-positive leukemia cells.
    Huang CH; Lee YC; Chiou JT; Shi YJ; Wang LJ; Chang LS
    Toxicol Appl Pharmacol; 2020 Apr; 397():115013. PubMed ID: 32305283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel Mechanism by a Bis-Pyridinium Fullerene Derivative to Induce Apoptosis by Enhancing the MEK-ERK Pathway in a Reactive Oxygen Species-Independent Manner in BCR-ABL-Positive Chronic Myeloid Leukemia-Derived K562 Cells.
    Sumi K; Tago K; Nakazawa Y; Takahashi K; Ohe T; Mashino T; Funakoshi-Tago M
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The potentiation of menadione on imatinib by downregulation of ABCB1 expression.
    Xiao FY; Zhou FJ; Yuan F; Kuang W; Zhou G; Zhou HH; Cao S
    Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):997-1004. PubMed ID: 32112424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quinacrine induces apoptosis in human leukemia K562 cells via p38 MAPK-elicited BCL2 down-regulation and suppression of ERK/c-Jun-mediated BCL2L1 expression.
    Changchien JJ; Chen YJ; Huang CH; Cheng TL; Lin SR; Chang LS
    Toxicol Appl Pharmacol; 2015 Apr; 284(1):33-41. PubMed ID: 25684043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pml and TAp73 interacting at nuclear body mediate imatinib-induced p53-independent apoptosis of chronic myeloid leukemia cells.
    Liu JH; Liu CC; Yen CC; Gau JP; Wang WS; Tzeng CH
    Int J Cancer; 2009 Jul; 125(1):71-7. PubMed ID: 19291793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The suppressive effect of arsenic trioxide on TET2-FOXP3-Lyn-Akt axis-modulated MCL1 expression induces apoptosis in human leukemia cells.
    Chen YJ; Huang CH; Shi YJ; Lee YC; Wang LJ; Chang LS
    Toxicol Appl Pharmacol; 2018 Nov; 358():43-55. PubMed ID: 30213730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of protein kinase CK2 by CX-5011 counteracts imatinib-resistance preventing rpS6 phosphorylation in chronic myeloid leukaemia cells: new combined therapeutic strategies.
    Salizzato V; Borgo C; Cesaro L; Pinna LA; Donella-Deana A
    Oncotarget; 2016 Apr; 7(14):18204-18. PubMed ID: 26919095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tyrosine kinase inhibitor resistance in chronic myeloid leukemia cell lines: investigating resistance pathways.
    Tang C; Schafranek L; Watkins DB; Parker WT; Moore S; Prime JA; White DL; Hughes TP
    Leuk Lymphoma; 2011 Nov; 52(11):2139-47. PubMed ID: 21718141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of extracellular signal-regulated kinase activity by sorafenib increases sensitivity to DNR in K562 cells.
    Xiao RZ; He CM; Xiong MJ; Ruan XX; Wang LL; Chen Y; Lin DJ
    Oncol Rep; 2013 May; 29(5):1895-901. PubMed ID: 23467984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistent STAT5-mediated ROS production and involvement of aberrant p53 apoptotic signaling in the resistance of chronic myeloid leukemia to imatinib.
    Cheng Y; Hao Y; Zhang A; Hu C; Jiang X; Wu Q; Xu X
    Int J Mol Med; 2018 Jan; 41(1):455-463. PubMed ID: 29115375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anthelmintic niclosamide suppresses transcription of BCR-ABL fusion oncogene via disabling Sp1 and induces apoptosis in imatinib-resistant CML cells harboring T315I mutant.
    Jin B; Wang C; Shen Y; Pan J
    Cell Death Dis; 2018 Jan; 9(2):68. PubMed ID: 29358661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stellettin B induces apoptosis in human chronic myeloid leukemia cells via targeting PI3K and Stat5.
    Chen Y; Zhou Q; Zhang L; Zhong Y; Fan G; Zhang Z; Wang R; Jin M; Qiu Y; Kong D
    Oncotarget; 2017 Apr; 8(17):28906-28921. PubMed ID: 28423649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amsacrine-induced apoptosis of human leukemia U937 cells is mediated by the inhibition of AKT- and ERK-induced stabilization of MCL1.
    Lee YC; Chen YJ; Huang CH; Chang LS
    Apoptosis; 2017 Mar; 22(3):406-420. PubMed ID: 27757735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inducible SHP-2 activation confers resistance to imatinib in drug-tolerant chronic myeloid leukemia cells.
    Li X; Pang J; Xue W; Wang Y; Tian T; Elgehama A; Wu X; Wu X; Sun Y; Qiu H; Shen Y; Xu Q
    Toxicol Appl Pharmacol; 2018 Dec; 360():249-256. PubMed ID: 30290167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of heme oxygenase-1 by Na+-H+ exchanger 1 protein plays a crucial role in imatinib-resistant chronic myeloid leukemia cells.
    Ma D; Fang Q; Wang P; Gao R; Wu W; Lu T; Cao L; Hu X; Wang J
    J Biol Chem; 2015 May; 290(20):12558-71. PubMed ID: 25802333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ceramide promotes apoptosis in chronic myelogenous leukemia-derived K562 cells by a mechanism involving caspase-8 and JNK.
    Nica AF; Tsao CC; Watt JC; Jiffar T; Kurinna S; Jurasz P; Konopleva M; Andreeff M; Radomski MW; Ruvolo PP
    Cell Cycle; 2008 Nov; 7(21):3362-70. PubMed ID: 18948750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phosphorylated Sp1 is the regulator of DNA-PKcs and DNA ligase IV transcription of daunorubicin-resistant leukemia cell lines.
    Nishida Y; Mizutani N; Inoue M; Omori Y; Tamiya-Koizumi K; Takagi A; Kojima T; Suzuki M; Nozawa Y; Minami Y; Ohnishi K; Naoe T; Murate T
    Biochim Biophys Acta; 2014; 1839(4):265-74. PubMed ID: 24530422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ribavirin Inhibits the Activity of mTOR/eIF4E, ERK/Mnk1/eIF4E Signaling Pathway and Synergizes with Tyrosine Kinase Inhibitor Imatinib to Impair Bcr-Abl Mediated Proliferation and Apoptosis in Ph+ Leukemia.
    Shi F; Len Y; Gong Y; Shi R; Yang X; Naren D; Yan T
    PLoS One; 2015; 10(8):e0136746. PubMed ID: 26317515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.